245 related articles for article (PubMed ID: 11208881)
1. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
Olsen JH; Hahnemann JM; Børresen-Dale AL; Brøndum-Nielsen K; Hammarström L; Kleinerman R; Kääriäinen H; Lönnqvist T; Sankila R; Seersholm N; Tretli S; Yuen J; Boice JD; Tucker M
J Natl Cancer Inst; 2001 Jan; 93(2):121-7. PubMed ID: 11208881
[TBL] [Abstract][Full Text] [Related]
2. Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.
Olsen JH; Hahnemann JM; Børresen-Dale AL; Tretli S; Kleinerman R; Sankila R; Hammarström L; Robsahm TE; Kääriäinen H; Bregård A; Brøndum-Nielsen K; Yuen J; Tucker M
Br J Cancer; 2005 Jul; 93(2):260-5. PubMed ID: 15942625
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
4. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
5. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in heterozygotes for ataxia-telangiectasia.
Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
[TBL] [Abstract][Full Text] [Related]
7. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.
Sankila R; Garwicz S; Olsen JH; Döllner H; Hertz H; Kreuger A; Langmark F; Lanning M; Möller T; Tulinius H
J Clin Oncol; 1996 May; 14(5):1442-6. PubMed ID: 8622057
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Swift M; Morrell D; Massey RB; Chase CL
N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
[TBL] [Abstract][Full Text] [Related]
9. Breast and other cancers in families with ataxia-telangiectasia.
Swift M; Reitnauer PJ; Morrell D; Chase CL
N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
Swift M; Lukin JL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
[TBL] [Abstract][Full Text] [Related]
11. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.
Athma P; Rappaport R; Swift M
Cancer Genet Cytogenet; 1996 Dec; 92(2):130-4. PubMed ID: 8976369
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
[TBL] [Abstract][Full Text] [Related]
14. Public health burden of cancer in ataxia-telangiectasia heterozygotes.
Swift M
J Natl Cancer Inst; 2001 Jan; 93(2):84-5. PubMed ID: 11208872
[No Abstract] [Full Text] [Related]
15. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.
Børresen AL; Andersen TI; Tretli S; Heiberg A; Møller P
Genes Chromosomes Cancer; 1990 Nov; 2(4):339-40. PubMed ID: 2268581
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
[TBL] [Abstract][Full Text] [Related]
17. Cancers in 44 families with ataxia-telangiectasia.
Morrell D; Chase CL; Swift M
Cancer Genet Cytogenet; 1990 Nov; 50(1):119-23. PubMed ID: 2253179
[TBL] [Abstract][Full Text] [Related]
18. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
19. Cancer risks in A-T heterozygotes.
Easton DF
Int J Radiat Biol; 1994 Dec; 66(6 Suppl):S177-82. PubMed ID: 7836845
[TBL] [Abstract][Full Text] [Related]
20. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
